Latest News and Press Releases
Want to stay updated on the latest news?
-
SupplySide Global 2026 expands to three expo hall days (Oct 28–30) at Mandalay Bay, featuring 1,600+ exhibitors, and new 'Pick Your Path' education format
-
LOS ANGELES, July 01, 2026 (GLOBE NEWSWIRE) -- SupplyTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout technology companies, products...
-
SUNRISE-FA 2 study parameters include LVMI primary endpoint, 6-month topline efficacy analysis, inclusion criteria focused on abnormal baseline LVMI and open-label trial design BLA supportive...
-
Longeveron (LGVN) granted Small or Medium-sized Enterprise (SME) status by the European Medicines Agency (EMA).
-
Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System
-
PYRUKYND (mitapivat) approved in the European Union for adults with thalassemia
-
Garfunkel Wild is pleased to announce that Steven E. Frankel, an accomplished litigator, has joined the firm as a partner in its Garden City, NY office.
-
ZUG, Switzerland, May 14, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company”), today announced the results from its 2026 Annual General Meeting held on...
-
Agios announces the submission of its sNDA to the FDA for the U.S. accelerated approval of mitapivat in sickle cell disease
-
Pipeline Advancing as Planned, Leading with OCS-01 Key Milestone Completion of LPLV in Both DIAMOND Phase 3 Trials; Data Readout on Track for June 2026Licaminlimab PREDICT-1 Trial in Active Site...